Decision Diagnostics Corp.
DECN · OTC
12/31/2020 | 12/31/2019 | 12/31/2018 | 12/31/2017 | |
|---|---|---|---|---|
| Revenue | $2 | $2 | $2 | $2 |
| % Growth | -16.8% | 6.4% | 18.9% | – |
| Cost of Goods Sold | $1 | $2 | $2 | $2 |
| Gross Profit | $0 | $1 | $0 | -$0 |
| % Margin | 25.2% | 35.7% | 13.7% | -3.7% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $2 | $2 | $2 | $2 |
| SG&A Expenses | $2 | $2 | $2 | $2 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $3 | $2 | $2 | $2 |
| Operating Income | -$2 | -$1 | -$2 | -$2 |
| % Margin | -106.7% | -54.4% | -82.9% | -125.7% |
| Other Income/Exp. Net | -$28 | -$2 | -$0 | -$1 |
| Pre-Tax Income | -$30 | -$3 | -$2 | -$3 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$30 | -$3 | -$2 | -$3 |
| % Margin | -1,499.1% | -131.7% | -100.2% | -159.1% |
| EPS | -0.11 | -0.021 | -0.018 | -0.032 |
| % Growth | -428.8% | -16.2% | 43.5% | – |
| EPS Diluted | -0.11 | -0.021 | -0.018 | -0.032 |
| Weighted Avg Shares Out | 267 | 150 | 125 | 94 |
| Weighted Avg Shares Out Dil | 267 | 150 | 125 | 94 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $27 | $3 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$2 | -$0 | -$2 | -$3 |
| % Margin | -121.6% | -4.9% | -82.9% | -140.3% |